chr22-37710101-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001039141.3(TRIOBP):​c.115-326C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.249 in 152,280 control chromosomes in the GnomAD database, including 5,652 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.25 ( 5652 hom., cov: 36)

Consequence

TRIOBP
NM_001039141.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.127

Publications

5 publications found
Variant links:
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]
TRIOBP Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 22-37710101-C-T is Benign according to our data. Variant chr22-37710101-C-T is described in ClinVar as [Benign]. Clinvar id is 1243015.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.386 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIOBPNM_001039141.3 linkc.115-326C>T intron_variant Intron 3 of 23 ENST00000644935.1 NP_001034230.1 Q9H2D6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIOBPENST00000644935.1 linkc.115-326C>T intron_variant Intron 3 of 23 NM_001039141.3 ENSP00000496394.1 Q9H2D6-1
ENSG00000100101ENST00000455236.4 linkn.*451-326C>T intron_variant Intron 9 of 12 5 ENSP00000477208.1 V9GYY5
TRIOBPENST00000492485.5 linkn.251-326C>T intron_variant Intron 2 of 4 1
TRIOBPENST00000344404.10 linkn.115-326C>T intron_variant Intron 2 of 21 2 ENSP00000340312.6 H7BXW4

Frequencies

GnomAD3 genomes
AF:
0.249
AC:
37850
AN:
152162
Hom.:
5658
Cov.:
36
show subpopulations
Gnomad AFR
AF:
0.0752
Gnomad AMI
AF:
0.376
Gnomad AMR
AF:
0.295
Gnomad ASJ
AF:
0.380
Gnomad EAS
AF:
0.302
Gnomad SAS
AF:
0.401
Gnomad FIN
AF:
0.361
Gnomad MID
AF:
0.294
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.275
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.249
AC:
37852
AN:
152280
Hom.:
5652
Cov.:
36
AF XY:
0.256
AC XY:
19026
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0751
AC:
3125
AN:
41586
American (AMR)
AF:
0.295
AC:
4516
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.380
AC:
1317
AN:
3468
East Asian (EAS)
AF:
0.302
AC:
1562
AN:
5172
South Asian (SAS)
AF:
0.400
AC:
1936
AN:
4834
European-Finnish (FIN)
AF:
0.361
AC:
3831
AN:
10610
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.302
AC:
20559
AN:
68002
Other (OTH)
AF:
0.275
AC:
581
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1442
2884
4327
5769
7211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
404
808
1212
1616
2020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.126
Hom.:
439
Bravo
AF:
0.235
Asia WGS
AF:
0.350
AC:
1216
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.6
DANN
Benign
0.87
PhyloP100
-0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62236745; hg19: chr22-38106108; API